Aspect Biosystems Named to Fast Company’s 2023 List of the Next Big Things in Tech
VANCOUVER, BC — Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of disease, announced that it has been named to Fast Company’s… Read More




